SGP:NASDAQ, SpyGlass Pharma Inc.

Why SGP stock fell on November 10

SpyGlass Pharma Inc. fell 10.9% on Tuesday, November 10, 2026, on 94,100 shares. No headline about SGP came out that day or the day before in the news feeds we follow, so the move may come from news we don't track, the sector or trading alone.

SGP stock overview

SpyGlass Pharma Inc. (SGP:NASDAQ) closed at $32.24 on November 16, 2026, down 1.95% on the day. The stock trades 19.2% below its 52-week high of $39.92 and 89.0% above its 52-week low of $17.06. Over the past year, it gained 22.1%. SpyGlass Pharma Inc. is part of the Health Care sector.

Key figures

Price
$32.24
Day change
-1.95%
Volume
246,130
Average volume
110,450
Market cap
1B+
52-week range
$17.06 – $39.92
50-day average
$28.78
200-day average
$24.89

Price action over the past year

In 195 trading sessions since February 9, 2026, SGP closed higher on 101 days (52%). Its best day was April 13, 2026 (+15.04%) and its worst was July 1, 2026 (-12.53%). The stock moved 10% or more in a single session 8 times.

Recent signals

SGP news

About SpyGlass Pharma Inc.

SpyGlass Pharma is a late-stage biopharmaceutical company dedicated to transforming the treatment paradigm for patients living with chronic eye conditions through long-acting, sustained drug delivery of approved medicines. The company's mission is to significantly improve the lives of patients with chronic eye conditions by developing durable drug delivery solutions that can empower patients and surgeons with confidence in long-term disease control and vision preservation. The SpyGlass Pharma platform, a novel, non-bioerodible drug delivery technology, is designed to be used with various well-established, approved medicines, including bimatoprost and other small molecules, providing flexibility to potentially treat a range of conditions in the front and back of the eye. The company was founded in 2019 by Malik Y. Kahook, M.D. and Glenn Sussman to solve the lack of ophthalmic innovations that capitalize on durable treatment options.

Similar stocks

Find more stocks like SGP with the Spikes, Gaps, Breakouts and Performance Tracker scanners.

Based on end-of-day data. For information only, not investment advice.